Anebulo Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Anebulo Pharmaceuticals, Inc.

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small …

Biotechnology
US, Lakeway [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Anebulo Pharmaceuticals, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Anebulo Pharmaceuticals, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Anebulo Pharmaceuticals, Inc..

End of ANEB's Analysis
CIK: 1815974 CUSIP: 034569103 ISIN: US0345691036 LEI: - UEI: -
Secondary Listings
ANEB has no secondary listings inside our databases.